
1.11 BATS BZX Real-Time Price As of Mar 30 | ![]() Today’s Change | 0.98 Today|||52-Week Range 16.65 | -4.31% Year-to-Date |
The 1 analysts offering 12-month price forecasts for Avenue Therapeutics Inc have a median target of 32.00, with a high estimate of 32.00 and a low estimate of 32.00. The median estimate represents a +2,782.88% increase from the last price of 1.11.
The current consensus among 1 polled investment analysts is to Buy stock in Avenue Therapeutics Inc. This rating has held steady since March, when it was upgraded from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.